Orion Biotechnology
Ottawa
About Orion Biotechnology
Orion Biotechnology is developing a pipeline of best-in-class biologic therapeutics based on Chemokine Analogue inhibitors, for the treatment of a broad range of serious unmet medical needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $20.3M
- Last round: Series Unknown (Jul 2024)
- Website: orionbiotechnology.com
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/orion-biotechnology-40949 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.